Wizmed Logo
FDA Drug Shortage List
Connect with us
Request a demo

Drugs on FDA Drug Shortage List

Pulled from FDA Drug Shortage List Daily
Total Listed
51
Currently in Shortage
34

Drug Shortage Resolved
13
Drug To be discontinued
4

Pharmaceutical Products on FDA drug shortage list Pulled daily from the FDA drug shortage website

Product Company Strength Status Availablity Reason Last Update Initial Post Date
Atropine Sulfate Injection Fresenius Kabi USA, LLC 8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20) Current Available Demand increase for the drug 2020-10-23 0000-00-00
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine w/EPI 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-461-57) Current Backordered. Next release November 2020. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine w/EPI 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-463-57) Current Backordered. Next release November 2020. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine MPF w/EPI 0.25% (25 mg per 10 mL) (2.5 mg per mL) SDV (NDC 63323-468-17) Current Backordered. Next release November 2020. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine MPF w/EPI .25% (75 mg per 30 mL) (2.5 mg per mL) SDV (NDC 63323-468-37) Current Backordered. Next release December 2020. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine MPF w/EPI 0.5% (50 mg per 10 mL) (5 mg per mL) SDV (NDC 63323-462-17) Current Backordered. Next release November 2020. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) SDV (NDC 63323-462-37) Current Backordered. Next release December 2020. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) Sterile-Pak, SDV (NDC 63323-462-31) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride and Fresenius Kabi USA, LLC Sensorcaine MPF w/EPI 0.75% (225 mg per 30 mL) (7.5 mg per mL) SDV (NDC 63323-460-37) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-467-57) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-17) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, Sterile-Pak, SDV (NDC 63323-464-31) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL) MPF, SDV (NDC 63323-466-17) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, SDV (NDC 63323-466-37) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, Sterile-Pak, SDV (NDC 63323-466-31) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-17) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Bupivacaine Hydrochloride Inje Fresenius Kabi USA, LLC Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-37) Current Available Demand increase for the drug 2020-10-23 2018-02-20
Cefepime Injection Fresenius Kabi USA, LLC 1 g single dose vial, sterile powder (NDC 63323-326-20) Current Available Demand increase for the drug 2020-10-23 2015-07-22
Cefepime Injection Fresenius Kabi USA, LLC 2 g single dose vial, sterile powder (NDC 63323-340-20) Current Available Demand increase for the drug 2020-10-23 2015-07-22
Cefotetan Disodium Injection Fresenius Kabi USA, LLC 1 g SDV (NDC 63323-0385-10) Current 9 mos expiry available by request. Next release December 2020. Manufacturing delay 2020-10-23 2014-08-14
Cefotetan Disodium Injection Fresenius Kabi USA, LLC 2 g SDV (NDC 63323-0386-20) Current Available Manufacturing delay 2020-10-23 2014-08-14
Cefotetan Disodium Injection Fresenius Kabi USA, LLC 10 g PBP (NDC 63323-0396-61) Current No release date available at this time. Manufacturing delay 2020-10-23 2014-08-14
Cefoxitin for Injection, USP Fresenius Kabi USA, LLC 1 g per vial; SDV; (NDC 63323-341-25) Current Backordered. Next release November 2020. Manufacturing delays 2020-10-23 2019-05-03
Cefoxitin for Injection, USP Fresenius Kabi USA, LLC 2 grams per vial; SDV; (NDC 63323-342-25) Current Backordered. Next release November 2020. Manufacturing delays 2020-10-23 2019-05-03
Cisatracurium Besylate Injecti Fresenius Kabi USA, LLC 10 mg (base) per 5 mL (2 mg per mL), Single dose vial, PF, (NDC 63323-416-05) Current Available Demand increase for the drug 2020-10-23 2020-04-08
Cisatracurium Besylate Injecti Fresenius Kabi USA, LLC 20 mg per 10 mL (2 mg per mL), Multiple dose vial, (NDC 63323-417-10) Current Available Demand increase for the drug 2020-10-23 2020-04-08
Cisatracurium Besylate Injecti Fresenius Kabi USA, LLC 200 mg per 20 mL (10 mg per mL), Single dose vial, PF, (NDC 63323-418-20) Current Backordered. Next release Q2 2021. Demand increase for the drug 2020-10-23 2020-04-08
Clindamycin Injection, USP Fresenius Kabi USA, LLC 300 mg per 2 mL (150 mg per mL); SDV; (NDC 63323-282-02) To Be Discontinued 2019-05-10 2019-05-10
Clindamycin Injection, USP Fresenius Kabi USA, LLC 600 mg per 4 mL (150 mg per mL); SDV; (NDC 63323-282-04) To Be Discontinued 2019-05-10 2019-05-10
Clindamycin Injection, USP Fresenius Kabi USA, LLC 900 mg per 6 mL (150 mg per mL); SDV; (NDC 63323-282-06) To Be Discontinued 2019-05-10 2019-05-10
Clindamycin Injection, USP Fresenius Kabi USA, LLC 9 grams per Pharmacy Bulk Package (150 mg per mL); (NDC 63323-282-60) To Be Discontinued 2019-05-10 2019-05-10
Deferoxamine Mesylate for Inje Fresenius Kabi USA, LLC 500 mg per vial, 10 mL vial (NDC 63323-597-10) Resolved 2019-09-10 2018-02-02
Dexamethasone Sodium Phosphate Fresenius Kabi USA, LLC 20 mg per 5 mL (4 mg per mL); MDV; Amber vial (NDC 63323-165-05) Current 4, 5, 6 month expiry available by request. Next release November 2020. Increase in demand 2020-10-23 2019-02-08
Dexamethasone Sodium Phosphate Fresenius Kabi USA, LLC 100 mg per 10 mL (10 mg per mL); MDV; Amber Vial (NDC 63323-516-10) Current Available Increase in demand 2020-10-23 2019-02-08
Dexamethasone Sodium Phosphate Fresenius Kabi USA, LLC 120 mg per 30 mL (4 mg per mL); MDV; Amber Vial (NDC 63323-165-30) Current Available Increase in demand 2020-10-23 2019-02-08
Dexamethasone Sodium Phosphate Fresenius Kabi USA, LLC 4 mg per mL (4 mg per mL); SDV; Amber Vial (NDC 63323-165-01) Current Available Increase in demand 2020-10-23 2019-02-08
Dexamethasone Sodium Phosphate Fresenius Kabi USA, LLC 10 mg per mL (10 mg per mL); SDV; Preservative Free; Amber Vial (NDC 63323-506-01) Current Available Increase in demand 2020-10-23 2019-02-08
Dexamethasone Sodium Phosphate Fresenius Kabi USA, LLC 4 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-106-10) Current Available Increase in demand 2020-10-23 2019-02-08
Dexamethasone Sodium Phosphate Fresenius Kabi USA, LLC 10 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-109-10) Current Available Increase in demand 2020-10-23 2019-02-08
Dexmedetomidine Injection Fresenius Kabi USA, LLC 80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 63323-671-20) Current Backordered. Next release December 2020. Demand increase for the drug 2020-10-23 2020-04-10
Dexmedetomidine Injection Fresenius Kabi USA, LLC 200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 25 (NDC 63323-671-50) Current Backordered. Next release December 2020. Demand increase for the drug 2020-10-23 2020-04-10
Dexmedetomidine Injection Fresenius Kabi USA, LLC 400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 63323-671-00) Current Backordered. Next release December 2020. Demand increase for the drug 2020-10-23 2020-04-10
Dexmedetomidine Injection Fresenius Kabi USA, LLC 200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 63323-421-02) Current Available Demand increase for the drug 2020-10-23 2020-04-10
Dextrose 5% Injection Bags Fresenius Kabi USA, LLC 5% Dextrose Injection, USP, 100mL (NDC 63323-624-61) Resolved 2019-09-23 2017-10-10
Dextrose 5% Injection Bags Fresenius Kabi USA, LLC 5% Dextrose Injection, USP, 250mL (NDC 63323-624-74) Resolved 2019-09-23 2017-10-10
Dextrose 5% Injection Bags Fresenius Kabi USA, LLC 5% Dextrose Injection, USP, 500mL (NDC 63323-624-75) Resolved 2019-09-23 2017-10-24
Dextrose 5% Injection Bags Fresenius Kabi USA, LLC 5% Dextrose Injection, USP, 1000mL (NDC 63323-624-10) Resolved 2019-09-23 2017-10-24
Diphenhydramine Injection Fresenius Kabi USA, LLC 50 mg per vial, Single dose, Amber vial (NDC 63323-664-01) Current Available Demand increase for the drug 2020-10-23 2018-09-14
Doxorubicin Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg/mL, 10 mL single-dose vial (NDC 63323-883-10) To Be Discontinued 2020-03-05 2020-03-05
Doxycycline Hyclate Injection Fresenius Kabi USA, LLC 100 mg per vial; amber vial; preservative free; lyophilized powder (NDC 63323-130-11) Current Backordered. Next release expected November 2020. Demand increase for the drug 2020-10-23 2020-07-10
Famotidine Injection Fresenius Kabi USA, LLC 20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 63323-739-12) Current Backordered. Next release October 2020. Demand increase for the drug 2020-10-23 2020-05-05
Famotidine Injection Fresenius Kabi USA, LLC 40 mg per 4 mL (10 mg per mL), mutilple dose vial, (NDC 63323-738-09) Current Available Demand increase for the drug 2020-10-23 2020-05-05
Famotidine Injection Fresenius Kabi USA, LLC 200 mg per 20 mL(10 mg per mL), multiple dose vial, (NDC 63323-738-20) Current Backordered. Next release Q4 2020. Demand increase for the drug 2020-10-23 2020-05-05
Fentanyl Citrate (Sublimaze) I Fresenius Kabi USA, LLC 1,000 mcg per 20 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-20) Current Available Increase in demand 2020-10-23 0000-00-00
Fentanyl Citrate (Sublimaze) I Fresenius Kabi USA, LLC 2,500 mcg per 50 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-50) Current Available Increase in demand 2020-10-23 0000-00-00
Fentanyl Citrate (Sublimaze) I Fresenius Kabi USA, LLC 50 mcg per 1 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-01) Current Available Increase in demand 2020-10-23 0000-00-00
Fentanyl Citrate (Sublimaze) I Fresenius Kabi USA, LLC 100 mcg per 2 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-02) Current Available Increase in demand 2020-10-23 0000-00-00
Fentanyl Citrate (Sublimaze) I Fresenius Kabi USA, LLC 250 mcg per 5 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-05) Current Available Increase in demand 2020-10-23 0000-00-00
Floxuridine for Injection, USP Fresenius Kabi USA, LLC 500 mg per vial (NDC 63323-145-07_ To be Discontinued 2020-09-30 2020-09-30
Furosemide Injection, USP Fresenius Kabi USA, LLC 20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02) Current Available Demand increase for the drug 2020-10-23 2020-04-07
Furosemide Injection, USP Fresenius Kabi USA, LLC 40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04) Current Available Demand increase for the drug 2020-10-23 2020-04-07
Furosemide Injection, USP Fresenius Kabi USA, LLC 100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10) Current Available Demand increase for the drug 2020-10-23 2020-04-07
Heparin Sodium and Sodium Chlo Fresenius Kabi USA, LLC 1,000 Units/500 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-77) Current Expected availability February 2021 Other 2020-10-23 2017-11-14
Heparin Sodium and Sodium Chlo Fresenius Kabi USA, LLC 2,000 Units/1000 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-10) Current Expected availability February 2021 Other 2020-10-23 2017-11-14
Hydralazine Hydrochloride Inje Fresenius Kabi USA, LLC 20 mg per mL, SDV (NDC 63323-614-01) Current Backordered. Next release expected November 2020. Manufacturing Delay 2020-10-23 2020-09-08
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC (Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06) Microvault Current Available 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC (Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-11) Microvault Current Available 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC 1 mg per 1 mL, Single dose vial, (NDC 63323-852-25) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC 2 mg per 1 mL, Single dose vial, (NDC 63323-853-25) Current Backordered. Next release October 2020. Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC 4 mg per 1 mL, Single dose vial, (NDC 63323-854-10) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC 10 mg per 1 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-10) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC 50 mg per 5 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-15) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC 500 mg per 50 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-50) Current Backorderd. Next release December 2020. Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC (Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-05) Current Check wholesalers for inventory Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC (Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-10) Blister pack Current Check wholesalers for inventory Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC (Dilaudid) 2 mg per 1 mL, prefilled syringe (NDC 76045-010-10) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2017-10-31
Hydromorphone Hydrochloride In Fresenius Kabi USA, LLC (Dilaudid) 4 mg per 1 mL, prefilled syringe (NDC 76045-011-10) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2017-10-31
Imipenem and Cilastatin for In Fresenius Kabi USA, LLC 250 mg/250 mg per vial, single dose vial, sterile powder (NDC 63323-349-25) Current Available Delay in shipping of the drug 2020-10-23 2015-05-22
Imipenem and Cilastatin for In Fresenius Kabi USA, LLC 500 mg/500 mg per vial, single dose vial, sterile powder (NDC 63323-322-25) Current Available Delay in shipping of the drug 2020-10-23 2015-05-22
Ketorolac Tromethamine Injecti Fresenius Kabi USA, LLC 15 mg per mL, Single Dose Amber Vial, (NDC 63323-161-01) Current Backordered. Next release November 2020. Manufacturing delays 2020-10-23 2018-03-23
Ketorolac Tromethamine Injecti Fresenius Kabi USA, LLC 30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-01) Current Available Manufacturing delays 2020-10-23 2018-03-23
Ketorolac Tromethamine Injecti Fresenius Kabi USA, LLC 30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-02) Current Available Manufacturing delays 2020-10-23 2018-03-23
Ketorolac Tromethamine Injecti Fresenius Kabi USA, LLC 15 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-107-10) Current Available 2020-10-23 2018-03-23
Ketorolac Tromethamine Injecti Fresenius Kabi USA, LLC 30 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-104-10) Current Available 2020-10-23 2018-03-23
Ketorolac Tromethamine Injecti Fresenius Kabi USA, LLC 60 mg per 2 mL, Single Dose, Simplist Syringe, (NDC 76045-105-20) Current Available 2020-10-23 2018-03-23
Leucovorin Calcium Lyophilized Fresenius Kabi USA, LLC 200 mg SDV (NDC 63323-710-50) Current Available Demand increase for the drug 2020-10-23 0000-00-00
Leucovorin Calcium Lyophilized Fresenius Kabi USA, LLC 500 mg SDV (NDC 63323-711-00) Current Available Manufacturing delay 2020-10-23 0000-00-00
Leucovorin Calcium Lyophilized Fresenius Kabi USA, LLC 500 mg per 50 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-50) Current Backordered. Next release July 2020. Manufacturing Delay 2020-05-15 0000-00-00
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10) discontinued Current Not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued Current Not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50)-NDC discontinued Current Not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31) Current Not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57) Current Not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57) Current Backordered. Next release December 2019. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80) Current Not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89) Current Not available at this time. Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37) Current Available Demand increase for the drug 2020-10-23 2012-02-22
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17) Current Backordered. Next release date not available at this time. Manufacturing delay 2020-10-23 2016-10-14
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17) Current Backordered. Next release December 2020. Manufacturing delay 2020-10-23 2016-10-14
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17) Current Available Manufacturing delay 2020-10-23 2016-10-14
Lidocaine Hydrochloride (Xyloc Fresenius Kabi USA, LLC Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17) Current Available Manufacturing delay 2020-10-23 2016-10-14
Methotrexate Sodium Injection Fresenius Kabi USA, LLC 1 gram per vial, 50 mL vial, SDV (NDC 63323-122-50) Resolved 2019-12-17 2017-04-24
Methotrexate Sodium Injection Fresenius Kabi USA, LLC 250 mg per 10 mL, vial (NDC 63323-123-10) Resolved 2019-12-17 2017-04-24
Metoclopramide Injection, USP Fresenius Kabi USA, LLC 10 mg per 2 mL, single use, prefilled syringe (NDC 76045-101-20) Resolved 2019-10-18 2017-10-23
Metoprolol Tartrate Injection, Fresenius Kabi USA, LLC 5 mg per 5 mL, SDV, PF (NDC 63323-660-05) Current Available Manufacturing delays 2020-10-23 2019-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 1 mg/mL, 2 mL prefilled syringe, 24 count (NDC 76045-0001-20) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 5 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0002-10) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02) Current 9 month dating available by request. Demand increase for the drug 2020-10-23 2020-04-02
Midazolam Injection, USP Fresenius Kabi USA, LLC 5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05) Current Available Demand increase for the drug 2020-10-23 2020-04-02
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 2 mg per 1 mL, Single dose vial, (NDC 63323-452-01) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 4 mg per 1 mL, Single dose vial, (NDC 63323-454-01) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 5 mg per 1 mL, Single dose vial, (NDC 63323-455-01) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 8 mg per 1 mL, Single dose vial, (NDC 63323-458-01) Current Backordered. Next release November 2020. Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 10 mg per 1 mL, Single dose vial, (NDC 63323-451-01) Current Backordered. Next release November 2020. Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-10) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-005-10) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 5 mg per 1 mL, Single-use prefilled syringe (NDC 76045-006-10) Current Available Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 8 mg per 1 mL, Single-use prefilled syring (NDC 76045-007-10) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 10 mg per 1 mL, Single-use prefilled syringe (NDC 76045-008-10) Current Backordered. Next release date not available at this time. Demand increase for the drug 2020-10-23 2017-10-31
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-11) Current Backordered. Next release October 2020. Other 2020-10-08 2020-10-08
Morphine Sulfate Injection, US Fresenius Kabi USA, LLC 4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-11) Current Availble Available 2020-10-08 2020-10-08
Ondansetron Hydrochloride Inje Fresenius Kabi USA, LLC Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02) Current 8 months expiry dating available by request. Demand increase for the drug 2020-10-23 2018-04-11
Ondansetron Hydrochloride Inje Fresenius Kabi USA, LLC Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20) Current Available Demand increase for the drug 2020-10-23 2018-04-11
Ondansetron Hydrochloride Inje Fresenius Kabi USA, LLC Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20) Current Available Demand increase for the drug 2020-10-23 2018-04-11
Oxytocin Injection, USP Synthe Fresenius Kabi USA, LLC 100 USP Units per 10 mL (10 USP units per mL); Multiple dose vial; (NDC 63323-012-10) Current 3, 7 & 8 month expiry dating available by request. Next release October 2020. Delay in manufacturing 2020-10-23 2019-11-06
Oxytocin Injection, USP Synthe Fresenius Kabi USA, LLC 300 USP Units per 30 mL (10 USP Units per mL); Multiple dose vial; (NDC 63323-012-30) Current Available Delay in manufacturing 2020-10-23 2019-11-06
Oxytocin Injection, USP Synthe Fresenius Kabi USA, LLC 10 USP Units per mL (10 USP units per mL); (NDC 63323-012-01)( NDC 63323-0012-11) Current 9 month expiry dating available by request. Next release November 2020. Delay in manufacturing 2020-10-23 2019-11-06
Paclitaxel Injection, USP Fresenius Kabi USA, LLC 30 mg/5 mL (6 mg/mL) MDV (NDC 63323-763-05) To be Discontinued 2020-03-30 2020-03-06
Pentamidine Isethionate (Nebup Fresenius Kabi USA, LLC 300 mg per vial, SDV, PF (NDC 63323-877-15) Resolved 2019-09-13 2019-08-02
Peritoneal Dialysis Solutions Fresenius Medical Care North A Peritoneal Dialysis Solutions (Delflex and Stay Safe) Resolved 2020-03-02 2014-08-08
Piperacillin and Tazobactam (Z Fresenius Kabi USA, LLC 2.25 g, single-dose vial (NDC 63323-981-21) Resolved 2020-02-21 2014-04-02
Piperacillin and Tazobactam (Z Fresenius Kabi USA, LLC 3.375 g, single dose vial, box of 10 (NDC 63323-983-21) Resolved 2020-02-21 2014-04-02
Piperacillin and Tazobactam (Z Fresenius Kabi USA, LLC 4.5 g, single dose vial, box of 10 (NDC 63323-982-52) Resolved 2020-02-21 2014-04-02
Progesterone Injection, USP Fresenius Kabi USA, LLC 500 mg per 10 mL, MDV (NDC 63323-0261-10) Resolved 2019-09-23 2017-12-21
Propofol Injectable Emulsion Fresenius Kabi USA, LLC 100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10) Current Shipping / Check wholesaler inventory 2020-10-08 2020-04-10
Propofol Injectable Emulsion Fresenius Kabi USA, LLC 200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29) Current Shipping / Check wholesaler inventory Demand increase for the drug 2020-10-08 2020-04-10
Propofol Injectable Emulsion Fresenius Kabi USA, LLC 500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50) Current Allocating to wholesalers / Check wholesaler inventory Demand increase for the drug 2020-10-08 2020-04-10
Propofol Injectable Emulsion Fresenius Kabi USA, LLC 1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65) Current Allocating to wholesalers / Check wholesaler inventory Demand increase for the drug 2020-10-08 2020-04-10
Remifentanil (Ultiva) Lyophili Fresenius Kabi USA, LLC 1 mg per vial, SDV (NDC 63323-723-03) Resolved 2020-03-02 2018-02-06
Remifentanil (Ultiva) Lyophili Fresenius Kabi USA, LLC 2 mg per vial, SDV (NDC 63323-724-05) Resolved 2020-03-02 2018-02-06
Remifentanil (Ultiva) Lyophili Fresenius Kabi USA, LLC 5 mg per vial, SDV (NDC 63323-725-10) Resolved 2020-03-02 2018-02-06
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (20 mg per 10 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-10) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (40 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-20) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 5 mg per mL / 0.5% (100 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-286-20) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 7.5 mg per mL / 0.75% (150 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-287-20) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 10 mg per mL / 1% (100 mg per 10 mL), Plastic Ampule, Sterile-Pak (63323-288-10) Current 6 months dating available by request. Next release October 2020. Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 10 mg per mL / 1% (200 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-288-20) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Free Flex Bag (NDC 63323-285-61) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Free Flex Bag (NDC 63323-285-63) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-285-65) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-285-64) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 5 mg per mL / 0.5% (500 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-286-00) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 5 mg per mL / 0.5% (1,000 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-286-63) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (20 mg per 10 mL), Single Dose Vial (NDC 63323-285-13) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 2 mg per mL / 0.2% (40 mg per 20 mL), Single Dose Vial (NDC 63323-285-23) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 5 mg per mL / 0.5% (150 mg per 30 mL), Single Dose Vial (NDC 63323-286-35) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 5 mg per mL / 0.5% (100 mg per 20 mL), Single Dose Vial (NDC 63323-286-23) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 7.5 mg per mL / 0.75% (150 mg per 20 mL), Single Dose Vial (NDC 63323-287-21) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 10 mg per mL / 1% (100 mg per 10 mL), Single Dose Vial (NDC 63323-288-11) Current Available Available 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 10 mg per mL / 1% (200 mg per 20 mL), Single Dose Vial (NDC 63323-288-21) Current Backordered. Next release date November 2020. Manufacturing Delay 2020-10-23 2018-03-23
Ropivacaine Hydrochloride Inje Fresenius Kabi USA, LLC 5 mg per mL / 0.5% (150 mg per 30 mL), Sterile-Pack, Single Dose Vial (NDC 63323-286-31) Current Available 2020-10-23 2018-03-23
Sodium Acetate Injection, USP Fresenius Kabi USA, LLC 32.8% 400 mEq 100mL PBP (NDC 63323-0032-00) Current Available Demand increase for the drug 2020-10-23 2016-03-23
Sodium Bicarbonate Injection, Fresenius Kabi USA, LLC 4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05) Current Available Demand increase for the drug 2020-10-23 2017-07-24
Sodium Bicarbonate Injection, Fresenius Kabi USA, LLC 8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL) (84 mg per mL)(NDC 63323-089-50) Current Backordered. Next release October 2020. Demand increase for the drug 2020-10-23 2017-07-24
Sodium Chloride 0.9% Injection Fresenius Kabi USA, LLC Sodium Chloride Injection USP, 0.9%, 50mL (NDC 63323-623-53) Resolved 2019-11-13 2014-01-15
Sodium Chloride 0.9% Injection Fresenius Kabi USA, LLC Sodium Chloride Injection USP, 0.9%, 100mL (NDC 63323-623-61) Resolved 2019-11-13 2014-01-15
Sodium Chloride 0.9% Injection Fresenius Kabi USA, LLC Sodium Chloride Injection USP, 0.9%, 250mL (NDC 63323-623-74) Resolved 2019-11-13 2014-01-15
Sodium Chloride 0.9% Injection Fresenius Kabi USA, LLC Sodium Chloride Injection USP, 0.9%, 500mL (NDC 63323-623-75) Resolved 2019-11-13 2014-01-15
Sodium Chloride 0.9% Injection Fresenius Kabi USA, LLC Sodium Chloride Injection USP, 0.9%, 1000mL (NDC 63323-623-76) Resolved 2019-11-13 2014-01-15
Sodium Chloride 0.9% Injection Fresenius Medical Care North A 1000ml (NDC 49230-300-10) Resolved 2019-11-13 2014-01-15
Sodium Chloride 23.4% Injectio Fresenius Kabi USA, LLC 30 mL vials (NDC 63323-0187-30) Current Backordered. Next release November 2020. Demand increase for the drug 2020-10-23 0000-00-00
Sodium Chloride 23.4% Injectio Fresenius Kabi USA, LLC 100 mL vials (NDC 63323-0088-61) Current Backordered. Next release October 2020. Demand increase for the drug 2020-10-23 0000-00-00
Sodium Chloride 23.4% Injectio Fresenius Kabi USA, LLC 200 mL vials (NDC 63323-0088-63) Current Backordered. Next release December 2020. Demand increase for the drug 2020-10-23 0000-00-00
Sodium Chloride Injection USP, Fresenius Kabi USA, LLC Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02) Current Available Increase in Demand 2020-10-23 2018-06-21
Sodium Chloride Injection USP, Fresenius Kabi USA, LLC Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10) Current Available Manufacturing delay 2020-10-23 2018-06-21
Sodium Chloride Injection USP, Fresenius Kabi USA, LLC Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20) Current Available Manufacturing delay 2020-10-23 2018-06-21
Sodium Chloride Injection USP, Fresenius Kabi USA, LLC Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00) Current Backordered. Next release date not available at this time. Increase in Demand 2020-10-23 2018-06-21
Sodium Phosphate Injection Fresenius Kabi USA, LLC Phosphorus 15 mmol/mL, 5 mL, Sodium 20 mEq/5mL vials (NDC 63323-170-05) Resolved 2019-08-07 2017-08-22
Sodium Phosphate Injection Fresenius Kabi USA, LLC Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL (NDC 63323-170-15) Resolved 2019-08-07 2017-08-22
Sterile Water Fresenius Kabi USA, LLC Single dose vial, 5 mL fill (NDC 63323-185-05) Resolved 2019-08-02 2018-01-23
Sterile Water Fresenius Kabi USA, LLC Single dose, plastic vial, 10 mL fill (NDC 63323-185-10) Resolved 2019-08-02 2018-01-23
Sterile Water Fresenius Kabi USA, LLC Single dose, plastic vial, 20 mL fill (NDC 63323-185-20) Resolved 2019-08-02 2018-01-23
Sterile Water Fresenius Kabi USA, LLC Single dose, plastic vial, 50 mL fill (NDC 63323-185-50) Resolved 2019-08-02 2018-01-23
Sterile Water Fresenius Kabi USA, LLC Single dose, tear top vial, 100 mL (NDC 63323-185-00) Resolved 2019-08-02 2018-01-23
Tobramycin Lyophilized Powder Fresenius Kabi USA, LLC 1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-51) Current Backordered. Next release expected November 2020. Other 2020-10-08 2020-08-24
Tobramycin Lyophilized Powder Fresenius Kabi USA, LLC 1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-55), Novaplus Current Backordered. Next release expected November 2020. Other 2020-10-08 2020-08-24
Vinblastine Sulfate Injection Fresenius Kabi USA, LLC 10 mg per 10 mL (1 mg per mL); MDV (NDC 63323-0278-10) Resolved Available 2020-03-03 2019-07-23

Do you have any questions? Reach out and let us know if you have any questions or recomendations.

WIZMED sources is data from the FDA, Dailymed, Medicaid data and other data sources and uses calculations to attempt to align datasets. The data feeds may run night, weekly and/or quarterly depending on data source. WIZMED nor any of its agencies, contractors, subcontractors or employees does not make any warranties, expressed or implied, with respect to data contained in these databases or files, and, furthermore, assume no liability for any party's use, or the results of such use, of any part of the database or files.